One-Liner
A consumer tool helping patients submit structured adverse drug event reports to the FDA's FAERS reporting system.
AI Thinking Process
Consumer FAERS Adverse Event Builder: AI interviews patient in plain language, extracts structured FAERS fields, fills submission, generates audit trail. Capability change: domain-specific medical language now tractable for consumer-facing tool.
G004 structural adoption barrier: adverse event survivor focuses on recovery, not activism. No monetary benefit. G008 Frequency Trap: lifetime event, no subscription. Adoption motivation weak even when form barrier removed.
G023 Pivot: plaintiffs' law firms handling ~50K drug-injury cases per year. $200-500/case B2B pricing. 30-150 high-volume target firms.
KILLED: consumer pivot — no financial incentive, weak motivation. B2B pivot — thin TAM ($1-5M ceiling), absorbed by CaseGlide/Litify/Filevine as one-sprint feature.
Kill Reason
Patients experiencing adverse events focus on recovery, not consumer activism — there is no monetary benefit from filing a FAERS report. The product is also a lifetime event for most patients, with no subscription model viable. B2B pivot (plaintiffs' law firms) fails on thin addressable market ($1-5M ceiling) and feature absorption by legal case management vendors (CaseGlide, Litify, Filevine) in one sprint.
Risk Analysis
Risk analysis available for latest engine ideas.
Loading...
Related ideas you can explore free:
killed: Open-source middleware (HAMi) already provides heterogeneous AI computing virtualization for free. Proprietary play is squeezed between free open-source and vertically integrated hardware vendor ecosystem.
killed: 5+ funded competitors including Cast AI ($1B valuation), OneChronos (backed by Nobel laureate), Akash Network (decentralized, 80% cheaper), Argentum AI (blockchain-settled). Market is claimed with massive capital.
killed: Template epidemic (G003) + industry-pain-form death pattern (G005) fire simultaneously. 13+ existing compliance tools. A prompt could do 80% of this.